| Gao, Ming |
NCT05830500: Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma |
|
|
| Recruiting | 4 | 360 | RoW | Anlotinib Hydrochloride Capsule | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Medullary Thyroid Cancer | 06/27 | 12/28 | | |
| Active, not recruiting | 3 | 291 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib | Loxo Oncology, Inc., Eli Lilly and Company | Medullary Thyroid Cancer | 05/23 | 02/26 | | |
NCT04787328: A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) |
|
|
| Recruiting | 2 | 30 | RoW | HA121-28 tablets | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Medullary Thyroid Carcinoma | 03/23 | 03/25 | | |
NCT05278364: Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor |
|
|
| Recruiting | 1/2 | 184 | RoW | SY-5007, SY-5007 Capsule | Shouyao Holdings (Beijing) Co. LTD | Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Solid Tumor | 01/25 | 02/25 | | |
NCT05395429: Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients |
|
|
| Recruiting | N/A | 1000 | RoW | | Genetron Health, Tianjin Medical University Cancer Institute and Hospital, First Affiliated Hospital, Sun Yat-Sen University, Yunnan Cancer Hospital, First Affiliated Hospital of Kunming Medical University | Thyroid Cancer | 11/23 | 12/23 | | |
NCT06677814: Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients |
|
|
| Recruiting | N/A | 700 | RoW | | Xijing Hospital | Premature Ejaculation, Anxiety | 03/25 | 05/26 | | |
NCT05994365: Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma |
|
|
| Recruiting | N/A | 380 | RoW | Anlotinib Hydrochloride Capsule | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Thyroid Neoplasms | 08/27 | 12/28 | | |
